Time
|
Session Title
|
Speaker
|
11:00 - 11:25 |
Use of the word 'probiotic' in the EU
|
Anja Derijck,
Regulatory Affairs Associate, Food Compliance Int.
|
11:30 – 11:55 |
A probiotic journey – getting to know a unique strain backed by 30 years of science |
Elisabet Nordström, PhD - Science Manager, Probi AB |
12:00 - 12:25 |
Women’s health through the life stages – harnessing the power of the microbiome creates new health opportunities
|
PhD Jane Thompson, Scientific Advisor, Human Health, Chr. Hansen A/S
PhD Adam Baker, Director of Science, Human Health, Chr. Hansen A/S
|
12:30 – 12:55 |
Break |
13:00 – 13:25 |
New science, innovation & the evolution of the probiotics market
|
Jennifer Cooper, CSO, LPS Health Science
|
13:30 –13:55 |
Lunch Break
|
14:00 – 14:25 |
North American probiotic, prebiotic and synbiotic marketing trends
|
William Rowe, President & CEO, Nutrasource
George Paraskevakos, Executive director, IPA
Len Monheit, CEO, Trust Transparency Center
|
14:30 – 14:55 |
Reimagining probiotic protection with breakthrough active material science technologies
|
Francois Bidet - Vice President of Business Development EMEA, Aptar CSP |
15:00 - 15:25 |
Bacillus subtilis DE111®: clinically validated probiotic spore. Overview of clinical documentation, application areas and new state-of-the-art germination study
|
PhD Casper Jorgensen, Project Manager, Deerland Probiotics & Enzymes A/S
|